Index
RUT
P/E
14.73
EPS (ttm)
4.36
Insider Own
3.42%
Shs Outstand
34.55M
Perf Week
-11.99%
Market Cap
2.22B
Forward P/E
17.76
EPS next Y
3.61
Insider Trans
-1.36%
Shs Float
33.38M
Perf Month
-44.52%
Enterprise Value
2.62B
PEG
12.25
EPS next Q
0.57
Inst Own
111.43%
Perf Quarter
-51.85%
Income
171.92M
P/S
3.49
EPS this Y
-56.63%
Inst Trans
-0.28%
Perf Half Y
-47.56%
Sales
635.89M
P/B
4.49
EPS next Y
71.12%
ROA
15.13%
Perf YTD
-47.24%
Book/sh
14.30
P/C
4.80
EPS next 5Y
1.45%
ROE
45.22%
52W High
156.00 -58.86%
Perf Year
-47.44%
Cash/sh
13.36
P/FCF
14.65
EPS past 3/5Y
- -
ROIC
12.84%
52W Low
62.89 2.05%
Perf 3Y
-15.20%
Dividend Est.
-
EV/EBITDA
20.57
Sales past 3/5Y
86.42% 88.21%
Gross Margin
58.76%
Volatility
7.63% 5.91%
Perf 5Y
196.72%
Dividend TTM
-
EV/Sales
4.12
EPS Y/Y TTM
244.83%
Oper. Margin
14.85%
ATR (14)
6.34
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
6.19
Sales Y/Y TTM
30.24%
Profit Margin
27.04%
RSI (14)
18.93
Dividend Gr. 3/5Y
- -
Current Ratio
6.74
EPS Q/Q
-71.22%
SMA20
-32.18%
Beta
2.00
Payout
0.00%
Debt/Eq
1.75
Sales Q/Q
21.18%
SMA50
-40.04%
Rel Volume
1.90
Prev Close
63.93
Employees
898
LT Debt/Eq
1.71
SMA200
-47.08%
Avg Volume
1.20M
Price
64.18
IPO
May 02, 2019
Option/Short
Yes / Yes
Trades
Volume
2,273,719
Change
0.39%
Date
Action
Analyst
Rating Change
Price Target Change
May-06-26 Downgrade
Oppenheimer
Outperform → Perform
Oct-23-25 Upgrade
Needham
Hold → Buy
$148
Oct-13-25 Initiated
Jefferies
Buy
$145
Sep-16-25 Initiated
Evercore ISI
Outperform
$155
Sep-04-25 Initiated
Stifel
Hold
$115
Dec-17-24 Downgrade
JP Morgan
Overweight → Neutral
$116 → $75
Nov-22-24 Downgrade
Needham
Buy → Hold
Oct-29-24 Reiterated
Oppenheimer
Outperform
$200 → $125
Oct-29-24 Reiterated
Needham
Buy
$208 → $109
Sep-24-24 Initiated
Robert W. Baird
Outperform
$200
Aug-21-24 Initiated
Needham
Buy
$208
Jun-06-24 Initiated
Cantor Fitzgerald
Overweight
$161
Jun-04-24 Initiated
Stephens
Overweight
$151
Mar-28-24 Initiated
Piper Sandler
Overweight
$95
Jul-19-23 Initiated
Robert W. Baird
Outperform
Aug-02-22 Upgrade
JP Morgan
Neutral → Overweight
$48
Oct-08-20 Downgrade
JP Morgan
Overweight → Neutral
$15
Apr-07-20 Initiated
Oppenheimer
Outperform
$25
May-28-19 Initiated
Morgan Stanley
Equal-Weight
May-28-19 Initiated
JP Morgan
Overweight
Show Previous Ratings
May-08-26 11:00AM
May-07-26 03:50PM
May-06-26 09:38AM
08:30AM
May-05-26 04:28PM
04:05PM
Loading…
04:05PM
Apr-29-26 09:26AM
Apr-23-26 07:00AM
Apr-21-26 04:05PM
Mar-19-26 09:00AM
Mar-05-26 02:01PM
(Investor's Business Daily)
-5.14%
Feb-27-26 07:00AM
Feb-25-26 12:35PM
11:50AM
10:17AM
01:07AM
Loading…
01:07AM
12:03AM
Feb-24-26 08:00PM
07:30PM
04:45PM
(Associated Press Finance)
04:05PM
Feb-23-26 10:33AM
09:15AM
Feb-20-26 04:05PM
Feb-17-26 05:25PM
04:05PM
Feb-16-26 10:52AM
Feb-13-26 03:32PM
Feb-12-26 05:15PM
Feb-10-26 04:05PM
08:00AM
Loading…
Feb-09-26 08:00AM
Feb-03-26 09:34PM
Feb-02-26 02:08PM
Jan-29-26 06:20AM
Jan-28-26 01:22PM
(Investor's Business Daily)
Jan-14-26 10:48AM
Jan-12-26 08:10AM
Jan-11-26 11:24PM
Jan-09-26 09:18AM
Dec-30-25 04:05PM
Dec-29-25 10:50AM
Dec-27-25 01:35PM
Dec-26-25 09:45AM
Dec-24-25 04:05PM
Dec-23-25 06:30AM
Dec-18-25 09:08AM
Dec-16-25 09:50AM
Dec-10-25 08:05AM
Dec-09-25 05:05PM
Dec-08-25 04:46PM
Dec-05-25 11:30AM
09:45AM
Dec-01-25 07:45PM
Nov-25-25 09:50AM
Nov-24-25 09:41PM
Nov-20-25 09:35AM
09:30AM
Nov-19-25 09:45AM
Nov-18-25 04:05PM
05:15AM
Nov-13-25 08:15AM
Oct-31-25 04:05PM
09:45AM
Oct-30-25 01:56PM
Oct-29-25 07:30PM
05:35PM
04:27PM
(Associated Press Finance)
04:05PM
Oct-28-25 01:17PM
(Investor's Business Daily)
Oct-26-25 05:02AM
Oct-23-25 09:39AM
Oct-22-25 10:00AM
Oct-15-25 04:05PM
Oct-14-25 03:28PM
(Investor's Business Daily)
Oct-08-25 09:37AM
Sep-25-25 12:54PM
Sep-24-25 09:45AM
Sep-22-25 02:00AM
Sep-19-25 01:37PM
09:50AM
Sep-17-25 09:40AM
Sep-16-25 09:35AM
Sep-10-25 12:59AM
Sep-08-25 04:59PM
Aug-29-25 12:24PM
11:30AM
Aug-25-25 04:05PM
11:17AM
Aug-22-25 09:50AM
Aug-21-25 02:03PM
(Investor's Business Daily)
Aug-20-25 09:45AM
Aug-14-25 08:35AM
Aug-13-25 02:16PM
Aug-12-25 09:30AM
Aug-06-25 09:50AM
Aug-05-25 12:58PM
(Investor's Business Daily)
Aug-04-25 09:45AM
08:00AM
Aug-02-25 03:21PM
Aug-01-25 04:05PM
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform. It focuses on the preservation of human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation. The company was founded by Waleed H. Hassanein in August 1998 and is headquartered in Andover, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Lovell Stephanie Director Mar 04 '26 Sale 149.62 1,193 178,497 2,866 Mar 06 06:12 PM Weill David Director Mar 04 '26 Option Exercise 14.20 3,571 50,708 15,705 Mar 06 06:09 PM Weill David Director Mar 04 '26 Sale 146.82 3,571 524,294 12,134 Mar 06 06:09 PM Hernandez Gerardo Chief Financial Officer Mar 04 '26 Option Exercise 71.17 7,236 515,001 20,601 Mar 04 09:40 PM Hernandez Gerardo Chief Financial Officer Mar 04 '26 Sale 147.21 7,236 1,065,212 14,689 Mar 04 09:40 PM Hernandez Gerardo Chief Financial Officer Mar 02 '26 Sale 139.12 375 52,170 14,689 Mar 04 09:40 PM Ranganath Anil P. See remarks Mar 02 '26 Sale 139.12 864 120,200 13,091 Mar 04 08:40 PM Corcoran Nicholas See remarks Mar 02 '26 Sale 139.12 2,966 412,630 29,831 Mar 04 08:40 PM GERARDO P HERNANDEZ Officer Mar 04 '26 Proposed Sale 147.21 7,236 1,065,183 Mar 04 04:34 PM STEPHANIE LOVELL Director Mar 04 '26 Proposed Sale 149.62 1,193 178,491 Mar 04 04:23 PM DAVID WEILL Director Mar 04 '26 Proposed Sale 146.82 3,571 524,295 Mar 04 04:18 PM Weill David Director Dec 03 '25 Option Exercise 14.20 5,000 71,000 17,134 Dec 05 04:30 PM Weill David Director Dec 03 '25 Sale 138.64 5,000 693,200 12,134 Dec 05 04:30 PM Hernandez Gerardo Chief Financial Officer Dec 04 '25 Sale 139.62 920 128,450 15,064 Dec 05 04:30 PM DAVID WEILL Director Dec 03 '25 Proposed Sale 138.64 5,000 693,210 Dec 03 04:06 PM Ranganath Anil P. See remarks Nov 25 '25 Option Exercise 93.88 3,000 281,640 16,955 Nov 26 04:30 PM Ranganath Anil P. See remarks Nov 25 '25 Sale 145.22 3,000 435,660 13,955 Nov 26 04:30 PM ANIL P RANGANATH Officer Nov 25 '25 Proposed Sale 145.22 3,000 435,674 Nov 25 04:11 PM Hassanein Waleed H President & CEO Nov 17 '25 Buy 114.00 8,775 1,000,350 495,009 Nov 18 04:30 PM Basile Edward M Director Oct 29 '25 Option Exercise 0.70 4,142 2,899 7,008 Oct 31 04:30 PM Basile Edward M Director Oct 29 '25 Sale 130.45 4,142 540,324 2,866 Oct 31 04:30 PM EDWARD BASILE Director Oct 29 '25 Proposed Sale 130.45 4,142 540,324 Oct 29 04:06 PM Hassanein Waleed H President & CEO Aug 06 '25 Buy 118.68 8,400 996,912 477,759 Aug 08 04:30 PM Hassanein Waleed H President & CEO Aug 07 '25 Buy 116.25 8,475 985,209 486,234 Aug 08 04:30 PM Basile Edward M Director Aug 04 '25 Option Exercise 0.70 4,143 2,900 7,009 Aug 05 04:30 PM Basile Edward M Director Aug 04 '25 Sale 125.51 4,143 519,988 2,866 Aug 05 04:30 PM EDWARD BASILE Director Aug 04 '25 Proposed Sale 125.51 4,143 519,988 Aug 04 04:06 PM Ranganath Anil P. See remarks Jun 09 '25 Sale 139.80 686 95,903 13,955 Jun 10 04:44 PM Basile Edward M Director May 27 '25 Option Exercise 0.70 5,000 3,500 7,866 May 29 04:30 PM Basile Edward M Director May 27 '25 Sale 126.45 5,000 632,250 2,866 May 29 04:30 PM EDWARD BASILE Director May 27 '25 Proposed Sale 126.45 5,000 632,250 May 27 04:18 PM Weill David Director May 23 '25 Sale 123.88 732 90,680 12,134 May 23 06:41 PM DAVID WEILL Director May 23 '25 Proposed Sale 123.88 732 90,683 May 23 05:26 PM